FDA Approves Trastuzumab Biosimilar [News in Brief]

Second biosimilar approved for cancer will be used for HER2-positive breast and stomach cancers.

from Cancer via ola Kala on Inoreader http://ift.tt/2ziHEjg
via IFTTT